Yeung J H
Department of Pharmacology, Faculty of Medicine, Chinese University of Hong Kong, Shatin, N.T.
Methods Find Exp Clin Pharmacol. 1994 Apr;16(3):163-72.
The effects of the angiotensin-converting enzyme (ACE) inhibitors captopril, enalaprilat and enalapril, and the bioactive peptides angiotensin II (Ang II), [Sar1,Ile8]angiotensin II ([Sar1,Ile8]Ang II), bradykinin and D-Arg[Hyp3,D-Phe7]bradykinin) on mitogen-induced proliferation of T-lymphocytes were evaluated in C57 mouse spleen cells. Captopril (CP) dose-dependently enhanced concanavalin A (Con A)-induced proliferation of T-lymphocytes, with the effective stimulatory concentration range between 0.02-10 mM. The mitogen-induced proliferative response was inhibited at high concentrations (> 10 mM) of CP which affected the number of viable cells. Enalapril dose-dependently inhibited Con A-induced T-lymphocyte proliferation at 0.44-20 mM. This was comparable to the ACE inhibitory peptide, which had a similar range. Enalaprilat, the active parent diacid of enalapril, also showed a weaker inhibitory effect on the Con A-induced proliferative response (4-20 mM). The bioactive peptides had little effect, except at a relatively high concentration. Angiotensin II (Ang II) at 0.05 mM inhibited the Con A-induced proliferative response while [Sar1,Ile8]Ang II, a specific antagonist of Ang II, had no effect. Both bradykinin and its specific antagonist, D-Arg[Hyp3,D-Phe7]bradykinin, had no effect on Con A-induced T-lymphocyte proliferation. The ACE inhibitors and bioactive peptides had little or no cytotoxic effects, except when present at or more than 5 mM. In conclusion, the effects of ACE inhibitors such as captopril and enalapril on Con A-induced T-lymphocyte proliferation were confirmed after a pilot study recently reported. These effects, especially with the stimulatory effect of CP, are unrelated to their ability to inhibit angiotensin-converting enzyme and perturbation of the bioactive peptides such as angiotensin II and bradykinin.
在C57小鼠脾细胞中评估了血管紧张素转换酶(ACE)抑制剂卡托普利、依那普利拉和依那普利,以及生物活性肽血管紧张素II(Ang II)、[Sar1,Ile8]血管紧张素II([Sar1,Ile8]Ang II)、缓激肽和D-Arg[Hyp3,D-Phe7]缓激肽对丝裂原诱导的T淋巴细胞增殖的影响。卡托普利(CP)剂量依赖性地增强了伴刀豆球蛋白A(Con A)诱导的T淋巴细胞增殖,有效刺激浓度范围在0.02 - 10 mM之间。在高浓度(>10 mM)的CP下,丝裂原诱导的增殖反应受到抑制,这影响了活细胞数量。依那普利在0.44 - 20 mM剂量依赖性地抑制Con A诱导的T淋巴细胞增殖。这与ACE抑制肽相当,其范围相似。依那普利的活性母体二酸依那普利拉对Con A诱导的增殖反应也显示出较弱的抑制作用(4 - 20 mM)。生物活性肽除在相对高浓度外几乎没有影响。0.05 mM的血管紧张素II(Ang II)抑制了Con A诱导的增殖反应,而Ang II的特异性拮抗剂[Sar1,Ile8]Ang II则没有作用。缓激肽及其特异性拮抗剂D-Arg[Hyp3,D-Phe7]缓激肽对Con A诱导的T淋巴细胞增殖均无作用。ACE抑制剂和生物活性肽除在5 mM或更高浓度时外,几乎没有或没有细胞毒性作用。总之,在最近报道的一项初步研究之后,证实了卡托普利和依那普利等ACE抑制剂对Con A诱导的T淋巴细胞增殖的影响。这些作用,尤其是CP的刺激作用,与其抑制血管紧张素转换酶的能力以及对血管紧张素II和缓激肽等生物活性肽的干扰无关。